Form 8-K - Current report:
SEC Accession No. 0001493152-24-031340
Filing Date
2024-08-12
Accepted
2024-08-12 17:05:46
Documents
15
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37555
2 ex99-1.htm EX-99.1 25413
3 ex99-1_001.jpg GRAPHIC 5696
  Complete submission text file 0001493152-24-031340.txt   252055

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE envb-20240812.xsd EX-101.SCH 3012
5 XBRL LABEL FILE envb-20240812_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE envb-20240812_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 241197826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)